"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study. Adding Imfinzi to the chemotherapy regimen of ...

The treatment goals and options for stomach cancer vary depending on how advanced the cancer is and how far it has spread. Surgery is often an effective treatment option for people with early-stage ...

For the first time, scientists have systematically analyzed somatic mutations in stomach lining tissue to unpick mutational processes, some of which can lead to cancer. The team also uncovered hints ...

SAN DIEGO, CA. (MAY 3, 2025) Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages — a shift that marks major progress in detecting one of the deadliest forms of ...

Doctors are increasingly detecting stomach tumors at an early stage, raising hopes for lifesaving treatment for one of the deadliest types of cancer. Stomach cancer, the disease that killed country ...

Data on disease stage at presentation and treatment outcomes were obtained from the King Hussein Cancer Center registry. Patients were staged according to the US SEER staging system, which classifies ...

Hope for Stomach Cancer amplifies patient voices and drives awareness at the nation’s leading oncology conference, ASCO 2025. “Bringing the gastroesophageal cancer patient voice directly into the ...

AstraZeneca’s Imfinzi is adding yet another landmark perioperative label to its belt with a new FDA approval that gives the drug the title of the first and only immunotherapy marketed to treat ...